We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMC icon
201
Vulcan Materials
VMC
$36.9B
$11.1M 0.12%
95,902
+83,415
+668% +$9.14M
AMP icon
202
Ameriprise Financial
AMP
$47.6B
$11M 0.12%
73,325
+4,156
+6% +$533K
MMM icon
203
3M
MMM
$91.9B
$10.9M 0.12%
83,910
-23,369
-22% -$2.94M
PAAS icon
204
Pan American Silver
PAAS
$18.6B
$10.9M 0.12%
360,000
-14,000
-4% -$332K
LULU icon
205
lululemon athletica
LULU
$13.4B
$10.9M 0.12%
35,019
-18,331
-34% -$4.69M
ZBRA icon
206
Zebra Technologies
ZBRA
$12.6B
$10.8M 0.11%
42,339
+17,853
+73% +$4.18M
TROW icon
207
T. Rowe Price
TROW
$25.5B
$10.8M 0.11%
87,080
+54,784
+170% +$6.25M
MKC icon
208
McCormick & Company Non-Voting
MKC
$13.6B
$10.6M 0.11%
118,100
+49,758
+73% +$4.1M
CERN
209
DELISTED
Cerner Corp
CERN
$10.6M 0.11%
154,224
+42,304
+38% +$2.91M
WCN
210
Waste Connections
WCN
$42.7B
$10.5M 0.11%
111,813
+59,846
+115% +$5.33M
ELV icon
211
Elevance Health
ELV
$82.1B
$10.5M 0.11%
39,869
-12,812
-24% -$3.42M
SHW icon
212
Sherwin-Williams
SHW
$80.7B
$10.1M 0.11%
52,596
-86,427
-62% -$15.6M
LRCX icon
213
Lam Research
LRCX
$365B
$10.1M 0.11%
312,030
+153,230
+96% +$4.18M
KEYS icon
214
Keysight
KEYS
$53.6B
$10M 0.11%
99,306
-83,499
-46% -$8.2M
IGMS
215
DELISTED
IGM Biosciences
IGMS
$9.96M 0.11%
136,368
+136,360
+1,704,500% +$8.28M
TECD
216
DELISTED
Tech Data Corp
TECD
$9.93M 0.1%
68,489
+37,612
+122% +$5.2M
ETFC
217
DELISTED
E*Trade Financial Corporation
ETFC
$9.86M 0.1%
198,272
+87,988
+80% +$3.79M
UPS icon
218
United Parcel Service
UPS
$96B
$9.79M 0.1%
88,087
-20,173
-19% -$2.01M
CDW icon
219
CDW
CDW
$17.6B
$9.62M 0.1%
82,786
+5,486
+7% +$594K
APH icon
220
Amphenol
APH
$184B
$9.49M 0.1%
396,164
+284,764
+256% +$6.36M
MET icon
221
MetLife
MET
$61.2B
$9.29M 0.1%
254,494
-141,396
-36% -$4.92M
EXEL icon
222
Exelixis
EXEL
$14B
$9.29M 0.1%
391,286
-267,230
-41% -$6.19M
BLD
223
DELISTED
TopBuild
BLD
$9.27M 0.1%
81,478
+36,843
+83% +$3.68M
COST icon
224
Costco
COST
$422B
$9.26M 0.1%
30,528
-9,080
-23% -$2.76M
XIFR
225
XPLR Infrastructure LP
XIFR
$1.19B
$9.24M 0.1%
180,156
+113,815
+172% +$5.51M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.